MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-20-0118652
White&Trust Pharmaceuticals (India) Private Limited
White&Trust Pharmaceuticals (India) Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹11.61 Cr
▲ 2% YoY
Net profit · FY 2024
₹52.08 Lakh
Net margin 4.5%
EBITDA · FY 2024
₹83.52 Lakh
EBITDA margin 7.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3.8 Lakh
Issued & subscribed
Open charges
₹12.15 Cr
Satisfied ₹70.6 Lakh
Company age
14 yrs
Est. 2012
Employees · EPFO
51
Provident fund records
About White&Trust Pharmaceuticals (India) Private Limited
Data last updated:
White&Trust Pharmaceuticals (India) Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2012PTC233018. Its GSTIN is 27AABCW2932M1Z1 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.8 Lakh. It is led by directors including Sameer Ashokrao Bhalerao and Girish Deorao Lad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Vilas R Dhabekar Sharda Chowk Jalalpura Near Patel Roadways Gandhibag, Nagpur, Maharashtra, India – 440002.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.61 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹52.08 Lakh (net margin 4.5%) and EBITDA of ₹83.52 Lakh (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 9% over five years.
The company has about 51 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.15 Cr and satisfied charges of ₹70.6 Lakh on record.
White&Trust Pharmaceuticals (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0118652). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of White&Trust Pharmaceuticals (India) Private Limited
CIN U24230MH2012PTC233018
Registration Number 233018
Incorporation Date 05 July 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-20-0118652
Key People
Sameer Ashokrao Bhalerao Director Girish Deorao Lad Director Vrushali Sameer Bhalerao Director Recognitions & Rankings of White&Trust Pharmaceuticals (India)
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Vilas R Dhabekar Sharda Chowk Jalalpura Near Patel Roadways Gandhibag, Nagpur, Maharashtra, India – 440002
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
White&Trust Pharmaceuticals (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of White&Trust Pharmaceuticals (India) Private Limited
The main business activity of White&Trust Pharmaceuticals (India) is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of White&Trust Pharmaceuticals (India) Private Limited FY 2025 filings available
White&Trust Pharmaceuticals (India) Private Limited reported revenue of ₹11.61 Cr (up 2% YoY) for FY 2024.
Revenue · FY 2024
₹11.61 Cr ▲ 2%
Net profit · FY 2024
₹52.08 Lakh margin 4.5%
EBITDA · FY 2024
₹83.52 Lakh margin 7.2%
Compounded Annual Growth Rate (CAGR) of White&Trust Pharmaceuticals (India) Private Limited
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 27%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 37%
5 years · compounded
▲ 12%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 2% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of White&Trust Pharmaceuticals (India) Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹83.52 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹52.08 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of White&Trust Pharmaceuticals (India) Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of White&Trust Pharmaceuticals (India) are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of White&Trust Pharmaceuticals (India) Private Limited
White&Trust Pharmaceuticals (India) has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sameer Ashokrao Bhalerao Also directs: Navitus Chemicals Private Limited | Director | 05 Jul 2012 | 14 Years 3 Months | Current |
| Girish Deorao Lad Also directs: Navitus Chemicals Private Limited | Director | 05 Feb 2022 | 4 Years 8 Months | Current |
| Vrushali Sameer Bhalerao Also directs: Stepping Stone Multitrade LLP | Director | 29 Sep 2017 | 9 Years 0 Months | Current |
| Shailesh Vilasrao Dhabekar Also directs: Navitus Chemicals Private Limited | Director | 05 Feb 2022 | 4 Years 8 Months | Current |
Peer Comparison of White&Trust Pharmaceuticals (India) Private Limited
White&Trust Pharmaceuticals (India) Private Limited is compared with the companies closest to it by revenue in the Machinery and Equipment industry (Chemical Retail and Distribution, Industrial Products Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Interface Devices India Private Limited | ₹11.65 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Pune, Maharashtra, India |
| United Petrofer Limited | ₹11.64 Cr (FY 2025) | •••• | •••• | -57.0% | •••• | Surat, Gujarat, India |
| Nextonic Smt Solutions Private Limited | ₹11.64 Cr (FY 2024) | •••• | •••• | 43.0% | •••• | Chennai, Tamil Nadu, India |
| Malwa Petro Products Private Limited | ₹11.64 Cr (FY 2025) | •••• | •••• | 2849.0% | •••• | Bhilwara, Rajasthan, India |
| Bluebell Dealer and Stockist Private Limited | ₹11.61 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| White&Trust Pharmaceuticals (India) Private Limited this company | ₹11.61 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Nagpur, Maharashtra, India |
| Sellers Safety Controls Private Limited | ₹11.6 Cr (FY 2015) | •••• | •••• | 31.0% | •••• | Lucknow, Uttar Pradesh, India |
| V K Oils Ltd | ₹11.58 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Kolkata, West Bengal, India |
| MPM Processors Private Limited | ₹11.57 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Guwahati, Assam, India |
| Kyokutoh Weld India Private Limited | ₹11.57 Cr (FY 2024) | •••• | •••• | 91.0% | •••• | Pune, Maharashtra, India |
| Ica Specialities Private Limited | ₹11.57 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below White&Trust Pharmaceuticals (India) by revenue in the Machinery and Equipment industry (Chemical Retail and Distribution, Industrial Products Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of White&Trust Pharmaceuticals (India) Private Limited
White&Trust Pharmaceuticals (India) Private Limited is audited by RUCHIYASHVERMA& ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RUCHIYASHVERMA& ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of White&Trust Pharmaceuticals (India) Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of White&Trust Pharmaceuticals (India) Private Limited
Open charges
₹12.15 Cr
Satisfied charges
₹70.6 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Oct 2024 | Others | ₹5.95 Cr | Open |
| 01 Feb 2023 | Others | ₹5 Cr | Open |
| 20 Jan 2021 | Others | ₹1.2 Cr | Open |
| 09 Oct 2014 | Uco Bank | ₹70.6 Lakh | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at White&Trust Pharmaceuticals (India) Private Limited
White&Trust Pharmaceuticals (India) Private Limited has a workforce of 51 employees as of Apr 08, 2024.
Employee count
51
Active EPFO establishments
1
Employee growth
6.25%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on White&Trust Pharmaceuticals (India) Private Limited
White&Trust Pharmaceuticals (India) Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Girish Deorao Lad was appointed as Director on 05 Feb 2022.
AGM
White&Trust Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
White&Trust Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 595.00 Lakh with Charge ID 101006958 was registered on 11 Oct 2024.
Charges
A charge with Others of Rs. 120.00 Lakh registered on 20 Jan 2021 with Charge ID 100414451 was modified on 20 Mar 2023.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 100678983 was registered on 01 Feb 2023.
Charges
A charge with Others of Rs. 500.00 Lakh registered on 01 Feb 2023 with Charge ID 100678983 was modified on 01 Feb 2023.
Appointed
Girish Deorao Lad was appointed as Director.
Appointed
Shailesh Vilasrao Dhabekar was appointed as Director.
Charges
A charge registered on 09 Oct 2014 via Charge ID 10524339 with Uco Bank was fully satisfied on 16 Feb 2021.
Charges
A charge with Others amounted to Rs. 120.00 Lakh with Charge ID 100414451 was registered on 20 Jan 2021.
Charges
A charge with Uco Bank of Rs. 70.60 Lakh registered on 09 Oct 2014 with Charge ID 10524339 was modified on 13 Aug 2020.
Ceased
Girish Deorao Lad ceased to be Director.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for White&Trust Pharmaceuticals (India) Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by White&Trust Pharmaceuticals (India) Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of White&Trust Pharmaceuticals (India) Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of White&Trust Pharmaceuticals (India) Private Limited
White&Trust Pharmaceuticals (India) has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCW2932M1Z1 | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of White&Trust Pharmaceuticals (India) Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about White&Trust Pharmaceuticals (India) Private Limited
White&Trust Pharmaceuticals (India) is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 July 2012 (14+ years old) and is registered under CIN U24230MH2012PTC233018.
White&Trust Pharmaceuticals (India) reported revenue of ₹11.61 Cr for FY 2024 (up 2% YoY).
White&Trust Pharmaceuticals (India) has 4 current directors:
- Sameer Ashokrao Bhalerao - Director
- Girish Deorao Lad - Director
- Vrushali Sameer Bhalerao - Director
- Shailesh Vilasrao Dhabekar - Director
White&Trust Pharmaceuticals (India) reported a net profit of ₹52.08 Lakh (net margin 4.5%) and EBITDA of ₹83.52 Lakh (EBITDA margin 7.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of White&Trust Pharmaceuticals (India) is 27% over three years and 9% over five years. In the latest year (FY 2024) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of White&Trust Pharmaceuticals (India) is 27AABCW2932M1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of White&Trust Pharmaceuticals (India) is U24230MH2012PTC233018. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
White&Trust Pharmaceuticals (India) was incorporated on 05 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of White&Trust Pharmaceuticals (India) by revenue are Interface Devices India Private Limited, United Petrofer Limited, Nextonic Smt Solutions Private Limited, Malwa Petro Products Private Limited, Bluebell Dealer and Stockist Private Limited and 5 more, all in the Machinery and Equipment industry (Chemical Retail and Distribution, Industrial Products Retail and Distribution, Pharmaceuticals).
Girish Deorao Lad was appointed as Director on 05 Feb 2022. Shailesh Vilasrao Dhabekar was appointed as Director on 05 Feb 2022. Girish Deorao Lad ceased to be Director on 30 Mar 2019. White&Trust Pharmaceuticals (India) has 6 board changes on record in total.
Yes, White&Trust Pharmaceuticals (India) is registered as a small enterprise under Udyam registration (number: UDYAM-MH-20-0118652).